Tabor Asset Management LP Takes Position in LENSAR, Inc. (NASDAQ:LNSR)

Tabor Asset Management LP bought a new stake in shares of LENSAR, Inc. (NASDAQ:LNSR - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 32,000 shares of the company's stock, valued at approximately $452,000. Tabor Asset Management LP owned about 0.27% of LENSAR as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently modified their holdings of the business. Draper Asset Management LLC purchased a new stake in shares of LENSAR in the first quarter valued at approximately $565,000. Geode Capital Management LLC lifted its holdings in LENSAR by 5.6% during the fourth quarter. Geode Capital Management LLC now owns 106,058 shares of the company's stock worth $948,000 after buying an additional 5,627 shares during the period. Huntleigh Advisors Inc. purchased a new stake in LENSAR during the first quarter worth $1,069,000. Finally, Renaissance Technologies LLC lifted its holdings in LENSAR by 13.3% during the fourth quarter. Renaissance Technologies LLC now owns 348,891 shares of the company's stock worth $3,119,000 after buying an additional 40,946 shares during the period. Institutional investors own 40.15% of the company's stock.

LENSAR Trading Down 0.2%

LNSR traded down $0.03 during midday trading on Friday, hitting $13.16. 4,120 shares of the company were exchanged, compared to its average volume of 93,290. The company's 50 day simple moving average is $13.19 and its 200 day simple moving average is $12.47. The firm has a market capitalization of $155.16 million, a price-to-earnings ratio of -2.72 and a beta of 0.50. LENSAR, Inc. has a 1-year low of $3.50 and a 1-year high of $17.31.

LENSAR (NASDAQ:LNSR - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The company reported ($2.32) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.16) by ($2.16). LENSAR had a negative return on equity of 737.30% and a negative net margin of 99.17%. The firm had revenue of $11.53 million during the quarter, compared to analyst estimates of $13.40 million.

Analyst Ratings Changes

A number of analysts have weighed in on LNSR shares. BTIG Research lowered LENSAR from a "strong-buy" rating to a "hold" rating in a report on Monday, March 24th. Lake Street Capital reiterated a "hold" rating and set a $15.00 price objective (down previously from $16.00) on shares of LENSAR in a report on Monday, March 24th.

LENSAR Company Profile

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.

Want to see what other hedge funds are holding LNSR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LENSAR, Inc. (NASDAQ:LNSR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.